Rheumatology Advance Access originally published online on July 27, 2005
Rheumatology 2005 44(9):1197-1198; doi:10.1093/rheumatology/kei035
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
LETTER TO THE EDITOR |
Methicillin-resistant Staphylococcus aureus septic arthritis: an emerging clinical syndrome
Division of Infectious Diseases, Caritas Saint Elizabeth's Medical Center and 1 Division of Geographic Medicine and Infectious Diseases, New England Medical Center, Boston, MA, USA
Correspondence to: J. J. Ross, Division of Infectious Diseases, Caritas Saint Elizabeth's Medical Center, 736 Cambridge Street, Boston, MA 02135, USA. E-mail: jrossmd@cchcs.org
| The first 10% of the full text of this article appears below. |
SIR, Despite the increasing importance of methicillin-resistant Staphylococcus aureus (MRSA) as a nosocomial and community pathogen, little is known about the clinical characteristics of MRSA septic arthritis. Prior descriptions of native joint MRSA septic arthritis in adults are confined to case reports [14]. In recent European studies, 68% cases of septic arthritis were due to MRSA [5, 6], although these patients were not described in detail. We reviewed cases of native joint septic arthritis from
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. B. Kherani MD BSc(Pha and K. Shojania MD Treatment of septic arthritis Can. Med. Assoc. J., October 9, 2007; 177(8): 899 - 900. [Full Text] [PDF] |
||||
